ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SALV Salvarx Group Plc

4.50
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Group Plc LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Salvarx Share Discussion Threads

Showing 351 to 369 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
21/10/2018
15:32
The news was stunning.
We have proven immuno-response. This is key. Necrosis (death) of the tumour. 90% of the drug remains in the tumour (think about that and the damage current methods do to surrounding tissue). Decrease in cancer related symptoms. All good. This will be taken massive by a major or a partner. In short Tumours die and proven engagement of the immune system.

An amazing weekend for any lucky shareholders of SALV. Well done all for holding.

jonesyboy 27
21/10/2018
15:18
Why are you interested Dex? Do you currently have a holding in SalvaRx or FFWD?
fig1
21/10/2018
12:25
I came on here today expecting a load of posts re some news yesterday, as expected in previous posts on here, that Intensity had made a world changing breakthrough and that Salvarx's 9% would be worth a fortune.

Instead just tumbleweed....

Presumably no such news / progress after all ?

dexdringle
19/10/2018
16:09
Well I don't want to be short this over the weekend
the stigologist
19/10/2018
01:29
Hmm just one trading day left before the BIG presentation
the stigologist
18/10/2018
13:32
…..the Portage update on 9th October merely confirmed that Canadian Stock Exchange is still 'checking the paperwork':



Good god. How long do these things take ?

dexdringle
17/10/2018
12:10
Fast Forward and Intensity really building up October 20th presentation on Twitter

Could/should be interesting weeks ahead

the stigologist
02/10/2018
08:09
Stig - are you old enough to remember Chesney Hawkes ?
dexdringle
02/10/2018
00:54
Portage has a history of creating value for its shareholders - one of its portfolio companies, Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") (NYSE:BHVN), was the second largest biotech IPO on NASDAQ in 2017. Portage subsequently announced a distribution in specie of its stock in Biohaven to its shareholders. Their initial US$7 million investment was worth in excess of US$100 million at the time of the IPO in 2017, and has almost doubled since then. Biohaven is now worth approximately US$1.3 billion. Portage has provided seed capital to four other biotech companies and will seek to evaluate new opportunities. I am excited at the potential of working with the Portage team to progress our combined portfolio.
the stigologist
30/9/2018
19:34
This could just be one of the most profitable trades Jim Mellon has been involved in.
fig1
25/9/2018
06:28
Their website contact form doesn’t work so have had to ask broker to try to get it.
bscuit
15/9/2018
15:17
Bscuit,

Did the company respond to your enquiry on that matter?

sweet karolina
13/9/2018
20:44
Much more important is taxation position of the distributed shares if not held in a ISA or similar.
bscuit
13/9/2018
17:20
What happens to 'free float' shares vis a vis Portage shares. Where do they end up? Can mm's profit from holding on to them?
fig1
13/9/2018
14:48
Seven separate sales of 713 shares each. This must be some kind of code !
dexdringle
12/9/2018
08:41
Portage website:

"Toronto, Ontario, August 28, 2018 (PBT.U: CSE; PTGEF: OTC Markets) Portage Biotech Inc. ("Portage" or the "Company") wishes to announce that, further to its news release of August 14, 2018 announcing the proposed acquisition of SalvaRx Limited from SalvaRx Group plc, it has now submitted draft shareholder meeting materials to CSE for review. Until the meeting materials have been approved by CSE for distribution, however, trading in the shares of Portage will remain halted. Upon clearance of the meeting materials, a further announcement will be made regarding the meeting date and a trade resumption date"

How long does it take the Canadian Stock Exchange to approve materials created to be used in a shareholder meeting?

I fear this is all going to end in disappointment....

dexdringle
09/9/2018
21:44
....I'm sure it will (disappoint)....
dexdringle
09/9/2018
21:18
It's 20th October ladies and gentlemen. Let's hope Intensity don't disappoint. Fig.
fig1
07/9/2018
08:48
Is it "post something completely irrelevant" day ?
dexdringle
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older

Your Recent History

Delayed Upgrade Clock